Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: Deposition of the pathological α-synuclein (αSynP) in the brain is the hallmark of synucleinopathies, including Parkinson disease (PD), Lewy body dementia (LBD), and multiple system atrophy (MSA). Whether real-time quaking-induced conversion (RT-QuIC) and protein misfolding cyclic amplification (PMCA) assays can sensitively detect skin biomarkers for PD and non-PD synucleinopathies remains unknown. OBJECTIVE: To develop sensitive and specific skin biomarkers for antemortem diagnosis of PD and other synucleinopathies. DESIGN, SETTING, AND PARTICIPANTS: This retrospective and prospective diagnostic study evaluated autopsy and biopsy skin samples from neuropathologically and clinically diagnosed patients with PD and controls without PD. Autopsy skin samples were obtained at 3 medical centers from August 2016 to September 2019, and biopsy samples were collected from 3 institutions from August 2018 to November 2019. Based on neuropathological and clinical diagnoses, 57 cadavers with synucleinopathies and 73 cadavers with nonsynucleinopathies as well as 20 living patients with PD and 21 living controls without PD were included. Specifically, cadavers and participants had PD, LBD, MSA, Alzheimer disease, progressive supranuclear palsy, or corticobasal degeneration or were nonneurodegenerative controls (NNCs). A total of 8 approached biopsy participants either refused to participate in or were excluded from this study due to uncertain clinical diagnosis. Data were analyzed from September 2019 to April 2020. MAIN OUTCOMES AND MEASURES: Skin αSynP seeding activity was analyzed by RT-QuIC and PMCA assays. RESULTS: A total of 160 autopsied skin specimens from 140 cadavers (85 male cadavers [60.7%]; mean [SD] age at death, 76.8 [10.1] years) and 41 antemortem skin biopsies (27 male participants [66%]; mean [SD] age at time of biopsy, 65.3 [9.2] years) were analyzed. RT-QuIC analysis of αSynP seeding activity in autopsy abdominal skin samples from 47 PD cadavers and 43 NNCs revealed 94% sensitivity (95% CI, 85-99) and 98% specificity (95% CI, 89-100). As groups, RT-QuIC also yielded 93% sensitivity (95% CI, 85-97) and 93% specificity (95% CI, 83-97) among 57 cadavers with synucleinopathies (PD, LBD, and MSA) and 73 cadavers without synucleinopathies (Alzheimer disease, progressive supranuclear palsy, corticobasal degeneration, and NNCs). PMCA showed 82% sensitivity (95% CI, 76-88) and 96% specificity (95% CI, 85-100) with autopsy abdominal skin samples from PD cadavers. From posterior cervical and leg skin biopsy tissues from patients with PD and controls without PD, the sensitivity and specificity were 95% (95% CI, 77-100) and 100% (95% CI, 84-100), respectively, for RT-QuIC and 80% (95% CI, 49-96) and 90% (95% CI, 60-100) for PMCA. CONCLUSIONS AND RELEVANCE: This study provides proof-of-concept that skin αSynP seeding activity may serve as a novel biomarker for antemortem diagnoses of PD and other synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. Y. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,100
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Hamilton, R. L. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00269.x · Cited by 754
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
Atarashi, R., Satoh, K., Sano, K., Fuse, T., Yamaguchi, N., Ishibashi, D., Matsubara, T., Nakagaki, T., Yamanaka, H., Shirabe, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2294 · Cited by 656
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630
Alpha‐synuclein RT ‐Qu IC in the CSF of patients with alpha‐synucleinopathies
Fairfoul, G., McGuire, L. I., Pal, S., Ironside, J. W., Neumann, J., Christie, S., Joachim, C., Esiri, M., Evetts, S. G., Rolinski, M., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.338 · Cited by 608
Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
Wilham, J. M., Orrú, C. D., Bessen, R. A., Atarashi, R., Sano, K., Race, B., Meade-White, K. D., Taubner, L. M., Timmes, A., & Caughey, B. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001217 · Cited by 501
Self-citationShahnawaz, M., Tokuda, T., Waragai, M., Mendez, N., Ishii, R., Trenkwalder, C., Mollenhauer, B., & Soto, C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4547 · Cited by 489
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology · doi:10.1111/neup.12189 · Cited by 460
Rossi, M., Candelise, N., Baiardi, S., Capellari, S., Giannini, G., Orrù, C. D., Antelmi, E., Mammana, A., Hughson, A. G., Calandra-Buonaura, G., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02160-8 · Cited by 451
Self-citationGroveman, B. R., Orrù, C. D., Hughson, A. G., Raymond, L. D., Zanusso, G., Ghetti, B., Campbell, K. J., Safar, J., Galasko, D., & Caughey, B. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0508-2 · Cited by 421
Self-citationA critical evaluation of the Braak staging scheme for Parkinson's disease
Burke, R. E., Dauer, W. T., & Vonsattel, J. P. G. (2008) · Annals of Neurology · doi:10.1002/ana.21541 · Cited by 377
Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372
Skin nerve α-synuclein deposits: A biomarker for idiopathic Parkinson disease
Donadio, V., Incensi, A., Leta, V., Giannoccaro, M. P., Scaglione, C., Martinelli, P., Capellari, S., Avoni, P., Baruzzi, A., & Liguori, R. (2014) · Neurology · doi:10.1212/wnl.0000000000000316 · Cited by 290
Self-citationNeuropathology of non-motor features of Parkinson disease
Dickson, D. W., Fujishiro, H., Orr, C., DelleDonne, A., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., Klos, K. J., & Ahlskog, J. E. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70769-2 · Cited by 266
Self-citationDoppler, K., Jentschke, H.-M., Schulmeyer, L., Vadasz, D., Janzen, A., Luster, M., Höffken, H., Mayer, G., Brumberg, J., Booij, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1684-z · Cited by 248
Self-citationCutaneous neuropathy in Parkinson’s disease: a window into brain pathology
Doppler, K., Ebert, S., Üçeyler, N., Trenkwalder, C., Ebentheuer, J., Volkmann, J., & Sommer, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1284-0 · Cited by 238
Self-citationVenkatraman, E. (1996) · Biometrika · doi:10.1093/biomet/83.4.835 · Cited by 219
Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease
Moda, F., Gambetti, P., Notari, S., Concha-Marambio, L., Catania, M., Park, K.-W., Maderna, E., Suardi, S., Haïk, S., Brandel, J.-P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404401 · Cited by 211
Manne, S., Kondru, N. C., Jin, H., Anantharam, V., Huang, X., Kanthasamy, A., & Kanthasamy, A. G. (2019) · Movement Disorders · doi:10.1002/mds.27907 · Cited by 159
Orru, C. D., Yuan, J., Appleby, B. S., Li, B., Li, Y., Winner, D., Wang, Z., Zhan, Y.-A., Rodgers, M. S., Rarick, J. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7785 · Cited by 147
Self-citationSkin nerve misfolded α‐synuclein in pure autonomic failure and Parkinson disease
Donadio, V., Incensi, A., Piccinini, C., Cortelli, P., Giannoccaro, M. P., Baruzzi, A., & Liguori, R. (2016) · Annals of Neurology · doi:10.1002/ana.24567 · Cited by 146
Self-citationBougard, D., Brandel, J., Bélondrade, M., Béringue, V., Segarra, C., Fleury, H. J., Laplanche, J., Mayran, C., Nicot, S., Green, A. J. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1257 · Cited by 146
Finding useful biomarkers for Parkinson’s disease
Chen-Plotkin, A. S., Albin, R., Alcalay, R., Babcock, D., Bajaj, V., Bowman, D., Buko, A., Cedarbaum, J., Chelsky, D., Cookson, M. R., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam6003 · Cited by 146
Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder
Antelmi, E., Donadio, V. A., Incensi, A., Plazzi, G., & Liguori, R. (2017) · Neurology · doi:10.1212/wnl.0000000000003989 · Cited by 140
Self-citationDistinctive distribution of phospho‐alpha‐synuclein in dermal nerves in multiple system atrophy
Doppler, K., Weis, J., Karl, K., Ebert, S., Ebentheuer, J., Trenkwalder, C., Klebe, S., Volkmann, J., & Sommer, C. (2015) · Movement Disorders · doi:10.1002/mds.26293 · Cited by 135
Self-citationZange, L., Noack, C., Hahn, K., Stenzel, W., & Lipp, A. (2015) · Brain · doi:10.1093/brain/awv138 · Cited by 129
Clinical availability of skin biopsy in the diagnosis of Parkinson's disease
Miki, Y., Tomiyama, M., Ueno, T., Haga, R., Nishijima, H., Suzuki, C., Mori, F., Kaimori, M., Baba, M., & Wakabayashi, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.027 · Cited by 126
Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study
Donadio, V. A., Incensi, A., El‐Agnaf, O. M. A., Rizzo, G., Vaikath, N. N., Sorbo, F. D., Scaglione, C. L. M., Capellari, S., Elia, A. E., Maserati, M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32588-8 · Cited by 123
Self-citationA new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits
Donadio, V. A., Incensi, A., Rizzo, G., Capellari, S., Pantieri, R., Maserati, M. S., Devigili, G., Eleopra, R., Defazio, G., Montini, F., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004146 · Cited by 117
Self-citationThe diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease
Gibbons, C. H., Garcia, J., Wang, N., Shih, L. C., & Freeman, R. (2016) · Neurology · doi:10.1212/wnl.0000000000002919 · Cited by 115
α‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK 2‐linked Parkinson's disease
Garrido, A., Fairfoul, G., Tolosa, E. S., Martí, M. J., Green, A., & the Barcelona LRRK2 Study Group (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.772 · Cited by 109
Manne, S., Kondru, N. C., Hepker, M., Jin, H., Anantharam, V., Lewis, M. M., Huang, X., Kanthasamy, A., & Kanthasamy, A. G. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09835-4 · Cited by 106
Sano, K., Atarashi, R., Satoh, K., Ishibashi, D., Nakagaki, T., Iwasaki, Y., Yoshida, M., Murayama, S., Mishima, K., & Nishida, N. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0624-1 · Cited by 101
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Visanji, N. P., Lang, A. E., & Kovacs, G. G. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0172-x · Cited by 100
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease
Lee, J. M., Derkinderen, P., Kordower, J. H., Freeman, R. L., Muñoz, D. G., Kremer, T., Zago, W. M., Hutten, S. J., Adler, C. H., Serrano, G. E., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw103 · Cited by 80
Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process
Uchikado, H., DelleDonne, A., Ahmed, Z., & Dickson, D. W. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000218449.17073.43 · Cited by 70
Lewy bodies in progressive supranuclear palsy
Mori, H., Oda, M., Komori, T., Arai, N., Takanashi, M., Mizutani, T., Hirai, S., & Mizuno, Y. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0555-3 · Cited by 66
Mfn2 Ablation in the Adult Mouse Hippocampus and Cortex Causes Neuronal Death
Han, S. H., Nandy, P., Austria, Q. M., Siedlak, S. L., Torres, S. L., Fujioka, H., Wang, W., & Zhu, X. (2020) · Cells · doi:10.3390/cells9010116 · Cited by 64
Self-citationThe Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s Disease
Visanji, N. P., Mollenhauer, B., Beach, T. G., Adler, C. H., Coffey, C. S., Kopil, C., Dave, K. D., Foroud, T., Chahine, L. M., Jennings, D. L., et al. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0366 · Cited by 56
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Becker, K., Wang, X., Stel, K. J. V., Chu, Y., Kordower, J. H., & Ma, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1007-y · Cited by 56
Self-citationDiffuse Lewy body disease manifesting as corticobasal syndrome
Kasanuki, K., Josephs, K. A., Ferman, T. J., Murray, M. E., Koga, S., Konno, T., Sakae, N., Parks, A. C., Uitti, R. J., van Gerpen, J. A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005828 · Cited by 49
Spine Topographical Distribution of Skin &agr;-Synuclein Deposits in Idiopathic Parkinson Disease
Donadio, V., Incensi, A., Rizzo, G., Scaglione, C., Capellari, S., Fileccia, E., Avoni, P., & Liguori, R. (2017) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/nlx021 · Cited by 47
Self-citationKuzkina, A., Schulmeyer, L., Monoranu, C., Volkmann, J., Sommer, C., & Doppler, K. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.03.003 · Cited by 42
Self-citationConcomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration
Yamashita, S., Sakashita, N., Yamashita, T., Tawara, N., Tasaki, M., Kawakami, K., Komohara, Y., Fujiwara, Y., Kamikawa, M., Nakagawa, T., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7491-8 · Cited by 17
Cited by
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Biomarkers for neurodegenerative diseases
Hansson, O. (2021) · Nature Medicine · doi:10.1038/s41591-021-01382-x · Cited by 1,159
Neuropathology and molecular diagnosis of Synucleinopathies
Koga, S., Sekiya, H., Kondru, N., Ross, O. A., & Dickson, D. W. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00501-z · Cited by 347
Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham, L. K., Liddelow, S. A., Temple, S., Benowitz, L. I., Di Polo, A., Wellington, C., Goldberg, J. L., He, Z., Duan, X., Bu, G., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00524-0 · Cited by 324
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
Okuzumi, A., Hatano, T., Matsumoto, G., Nojiri, S., Ueno, S.-I., Imamichi-Tatano, Y., Kimura, H., Kakuta, S., Kondo, A., Fukuhara, T., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02358-9 · Cited by 313
Metadata
- Authors
- Wang, Z., Becker, K., Donadio, V., Siedlak, S., Yuan, J., Rezaee, M., Incensi, A., Kuzkina, A., Orrú, C. D., Tatsuoka, C., Liguori, R., Gunzler, S. A., Caughey, B., Jimenez-Capdeville, M. E., Zhu, X., Doppler, K., Cui, L., Chen, S. G., Ma, J., & Zou, W.-Q.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2021-01-01
- Volume
- 78
- Issue
- 1
- Pages
- 30
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W3088907309
- Cited by
- 253
- References
- 50
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.